Aspirin inhibits the formation of pentosidine, a cross-linking advanced glycation end product, in collagen.
Diabetes Research and Clinical Practice (2007)
- PubMed: 17383766
Available from www.ncbi.nlm.nih.gov
or
Abstract
Aspirin showed an inhibitory effect on the formation of pentosidine, a cross-linking advanced glycation endproduct, in collagen incubated with glucose in vitro. IC(50) was evaluated at 10mmol/l. Aspirin might act by metallic ion chelating (as did EDTA and DTPA) and by oxygen radical scavenging. Since aspirin was reported to inhibit retinopathy in diabetic dogs, it could act partly by inhibiting advanced glycation endproduct accumulation in long-lived proteins like collagens.
Author-supplied keywords
Related papers
Available from www.ncbi.nlm.nih.gov
Page 1
Page 2
Readership Statistics
6 Readers on Mendeley
by Discipline
50% Medicine
by Academic Status
50% Ph.D. Student
17% Student (Master)
17% Post Doc
by Country
33% United Kingdom
17% Italy
17% Iceland
Sign up today - FREE
Mendeley saves you time finding and organizing research. Learn more
- All your research in one place
- Add and import papers easily
- Access it anywhere, anytime
